Jonathan Lee
Stock Analyst at Guggenheim
(1.26)
# 2,560
Out of 4,412 analysts
16
Total ratings
20%
Success rate
-8.63%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TIXT TELUS International (Cda) | Initiates: Neutral | $9 | $8.07 | +11.52% | 1 | Mar 19, 2024 | |
| DXC DXC Technology Company | Initiates: Neutral | $22 | $20.37 | +8.00% | 1 | Mar 19, 2024 | |
| CTSH Cognizant Technology Solutions | Initiates: Neutral | $80 | $66.76 | +19.83% | 1 | Mar 19, 2024 | |
| TASK TaskUs | Initiates: Neutral | $13 | $11.30 | +15.04% | 1 | Mar 19, 2024 | |
| DAVA Endava | Initiates: Buy | $60 | $29.10 | +106.19% | 1 | Mar 19, 2024 | |
| EPAM EPAM Systems | Initiates: Buy | $350 | $237.13 | +47.60% | 1 | Mar 19, 2024 | |
| GLOB Globant | Initiates: Buy | $250 | $179.14 | +39.56% | 1 | Mar 19, 2024 | |
| INFY Infosys | Initiates: Neutral | $20 | $17.01 | +17.58% | 1 | Mar 19, 2024 | |
| PRFT Perficient | Initiates: Neutral | $65 | $42.70 | +52.22% | 5 | Mar 19, 2024 | |
| TTEC TTEC Holdings | Initiates: Sell | $8 | $7.76 | +3.09% | 1 | Mar 19, 2024 | |
| ACN Accenture | Initiates: Buy | $425 | $309.00 | +37.54% | 1 | Mar 19, 2024 | |
| PTCT PTC Therapeutics | Maintains: Equal-Weight | $54 → $40 | $25.49 | +56.92% | 1 | Oct 28, 2022 |
TELUS International (Cda)
Mar 19, 2024
Initiates: Neutral
Price Target: $9
Current: $8.07
Upside: +11.52%
DXC Technology Company
Mar 19, 2024
Initiates: Neutral
Price Target: $22
Current: $20.37
Upside: +8.00%
Cognizant Technology Solutions
Mar 19, 2024
Initiates: Neutral
Price Target: $80
Current: $66.76
Upside: +19.83%
TaskUs
Mar 19, 2024
Initiates: Neutral
Price Target: $13
Current: $11.30
Upside: +15.04%
Endava
Mar 19, 2024
Initiates: Buy
Price Target: $60
Current: $29.10
Upside: +106.19%
EPAM Systems
Mar 19, 2024
Initiates: Buy
Price Target: $350
Current: $237.13
Upside: +47.60%
Globant
Mar 19, 2024
Initiates: Buy
Price Target: $250
Current: $179.14
Upside: +39.56%
Infosys
Mar 19, 2024
Initiates: Neutral
Price Target: $20
Current: $17.01
Upside: +17.58%
Perficient
Mar 19, 2024
Initiates: Neutral
Price Target: $65
Current: $42.70
Upside: +52.22%
TTEC Holdings
Mar 19, 2024
Initiates: Sell
Price Target: $8
Current: $7.76
Upside: +3.09%
Accenture
Mar 19, 2024
Initiates: Buy
Price Target: $425
Current: $309.00
Upside: +37.54%
PTC Therapeutics
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $54 → $40
Current: $25.49
Upside: +56.92%